Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Real-time Estimate Cboe BZX 01:51:58 2024-03-28 pm EDT 5-day change 1st Jan Change
782.5 USD +0.55% Intraday chart for Eli Lilly and Company +1.96% +34.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Advance in Afternoon Trading MT
Eli Lilly's Weight-Loss Drug Faces Shortage in US MT
SEIU Benefit Plans Master Trust Files a Notice of Exempt Solicitation to Eli Lilly and Company CI
Novo Nordisk, Eli Lilly, Sanofi Control More Than 90% of Global Insulin Market, JAMA Study Shows MT
Health Care Climbs on Weight-Loss Drug Excitement -- Health Care Roundup DJ
Sector Update: Health Care Stocks Rise Tuesday Afternoon MT
Amazon Pharmacy Reaping Benefits of Demand for Anti-Obesity Drugs, Executive Says MT
Eli Lilly's Zepbound Set to Be Key 2024 Revenue Maker as Weight-Loss Drug Usage Surges MT
Novo ready to seek German insurance coverage of Wegovy for heart use RE
Eli Lilly and Company Receives a Shareholder Proposal from The Service Employees International Union Pension Plans Master Trust CI
Wegovy to be covered by US Medicare for heart disease patients RE
Wegovy to be covered by US Medicare for heart disease patients RE
Eli Lilly: recycling solution for insulin pens CF
U.S. Government Spending on Weight-Loss Drugs Would Raise Deficit, CBO Says DJ
German health ministry says Ozempic exports are not a concern RE
Capstan Therapeutics, Inc. announced that it has received $175 million in funding from a group of investors CI
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers RE
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time RE
JPMorgan Raises Eli Lilly's Price Target to $850 From $775, Maintains Overweight Rating MT
What has UnitedHealth restored and what is next after major hack? RE
Eli Lilly's Phase 3 Trial of Tirzepatide in Sleep Apnea Likely to Miss Expectations, UBS Says MT
Global markets live: Adidas, EON, Sandoz, Bayer, Boeing... Our Logo
Not a care in the world Our Logo
Eli Lilly: delivery agreement with Amazon Pharmacy CF
Eli Lilly Teams Up with Amazon Pharmacy for Drug Home Deliveries MT
Chart Eli Lilly and Company
More charts
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
778.2 USD
Average target price
797.4 USD
Spread / Average Target
+2.47%
Consensus